IDO1 and inflammatory bowel disease: IDO expression by MSCs suppresses immune responses in Th1-mediated diseases, such as inflammatory bowel diseases, malignant tumor diseases, experimental autoimmune encephalomyelitis, collagen-induced arthritis, multiple sclerosis, and allograft rejection [24,46–51].